Study to Estimate the Burden of Herpes Zoster and Postherpetic Neuralgia in Spain
NCT01521286 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 552
Last updated 2015-09-28
Summary
The purpose of this study is to collect data on the incidence, complications and impact on quality of life of herpes zoster (HZ) disease in adults \>=50 years of age in Spain. This study will also collect data on costs related to the HZ disease, especially postherpetic neuralgia (PHN)
Conditions
- Herpes Zoster
Interventions
- OTHER
-
Data collection
HZ and PHN booklet questionnaire and zoster brief pain inventory (ZBPI) questionnaire.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2014-11-30
- Completion
- 2015-05-31
Countries
- Spain
Study Locations
More Related Trials
-
An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.
NCT04950712 ·Status: COMPLETED
-
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
NCT01165203 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Herpes Zoster Characteristics and Costs in Cancer Population.
NCT06207487 ·Status: NOT_YET_RECRUITING
-
A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster
NCT05492591 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster
NCT01827839 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia
NCT02412917 ·Status: TERMINATED ·Phase: PHASE3
-
Phase III Study of ASP2151 in Herpes Zoster Patients
NCT01959841 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity Study of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) With a Prior Episode of Herpes Zoster
NCT04091451 ·Status: COMPLETED ·Phase: PHASE3
-
VZV PCR Sampling Validation Study
NCT00501670 ·Status: COMPLETED
-
Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected Patients
NCT00127608 ·Status: COMPLETED ·Phase: PHASE3
-
A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes
NCT05298254 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes Zoster
NCT02151240 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting
NCT00689013 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Oral Famciclovir Versus Aciclovir Treatment in Patients With Herpes Zoster
NCT01327144 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster
NCT00006131 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of SYS6017 in Healthy Participants Aged 40 Years or More
NCT06954818 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study of the Characteristics of Patients Diagnosed With Recurrent Symptomatic Genital Herpetic Disease
NCT05500053 ·Status: COMPLETED
-
Dose-finding Study of ASP2151 in Subjects With Herpes Zoster
NCT00487682 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection
NCT01915212 ·Status: COMPLETED ·Phase: PHASE1
-
Occlusion vs Standard Treatment for the Treatment of Herpes Zoster
NCT04258930 ·Status: UNKNOWN ·Phase: NA
-
Phase III Study of ASP2151 in Herpes Simplex Patients
NCT01959295 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Vacyless® Versus Valtrex® in Patients With Herpes Zoster
NCT02152800 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells
NCT02090803 ·Status: COMPLETED
-
Open-label Study of ASP2151 in Herpes Simplex Patients
NCT02209324 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systems
NCT00002315 ·Status: COMPLETED ·Phase: PHASE3